Увеличение на броя ретикулоцити ≥ 40 000/ µl или повишаване на Hb ≥ 1 g/ dl
56 Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to maintain haemoglobin at that level.